This chart shows the patent expirations for cream dosed drugs over the next decade. The term of drug patents varies. The basic term for a patent is 20 years from…
Source
Annual Drug Patent Expirations for ADVIL+DUAL+ACTION+WITH+ACETAMINOPHEN Advil Dual Action With Acetaminophen is a drug marketed by Haleon Us Holdings and is included in one NDA. It is available from two…
Source
New patent for Haleon Us drug ADVIL DUAL ACTION WITH ACETAMINOPHEN Read Post »
Annual Drug Patent Expirations for OGSIVEO Ogsiveo is a drug marketed by Springworks and is included in one NDA. It is available from one supplier. There are fifteen patents protecting…
Source
This chart shows the pharmaceutical companies with patents in the most countries. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…
Source
Which pharmaceutical companies have the greatest global patent coverage? Read Post »
VELTASSA (patiromer sorbitex calcium) Vifor pharma Patent: 8,889,115 Expiration: Mar 30, 2024 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact…
Source
Drug Patent Expirations for the Week of March 24, 2024 Read Post »
Annual Drug Patent Expirations for ATORVALIQ Atorvaliq is a drug marketed by Cmp Dev Llc and is included in one NDA. It is available from one supplier. There are two…
Source
Annual Drug Patent Expirations for LUTATHERA Lutathera is a drug marketed by Aaa Usa Inc and is included in one NDA. It is available from one supplier. There are two…
Source
Annual Drug Patent Expirations for JENTADUETO+XR Jentadueto Xr is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from one supplier. There are eight…
Source
New patent for Boehringer Ingelheim drug JENTADUETO XR Read Post »
Annual Drug Patent Expirations for JENTADUETO Jentadueto is a drug marketed by Boehringer Ingelheim and is included in two NDAs. It is available from one supplier. There are ten patents…
Source
New patent for Boehringer Ingelheim drug JENTADUETO Read Post »
Annual Drug Patent Expirations for TRADJENTA Tradjenta is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from three suppliers. There are eight patents…
Source
New patent for Boehringer Ingelheim drug TRADJENTA Read Post »
Get new actionable insights and updates from BiotechBlog
